| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 02/17/2011 | US20110038959 Plant-origin drug for preventing or improving hyperuricemia |
| 02/17/2011 | US20110038946 Release of antibiotic from injectable, biodegradable polyurethane scaffolds for enhanced bone fracture healing |
| 02/17/2011 | US20110038924 Osteoarthritis gene therapy |
| 02/17/2011 | US20110038913 Polymeric endoprostheses with modified erosion rates and methods of manufacture |
| 02/17/2011 | US20110038885 Chemokine analogs |
| 02/17/2011 | US20110038877 Interleukin-6 antagonists |
| 02/17/2011 | US20110038868 Il-17 homologous polypeptides and therapeutic uses thereof |
| 02/17/2011 | US20110038844 Compositions for treating an arthritic condition |
| 02/17/2011 | US20110038835 Anilides and analogs as rho kinase inhibitors |
| 02/17/2011 | CA2771056A1 Fgf receptor-activating n-acyl octasaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | CA2771055A1 Fgf receptor-activating n-sulfate oligosaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | CA2770583A1 Pharmaceutical composition for relieving pain |
| 02/17/2011 | CA2769695A1 Pharmaceutical composition and administrations thereof |
| 02/16/2011 | EP2284192A2 Camelidae antibodies for sublingual administration |
| 02/16/2011 | EP2284189A2 Nucleic acid molecules encoding fibroblast growth factor-like (FGF-like) polypeptides |
| 02/16/2011 | EP2284172A1 Immunomodulating heterocyclic compounds |
| 02/16/2011 | EP2284160A1 Pyrimidine derivative having cell-protecting activity and use thereof |
| 02/16/2011 | EP2284149A1 Selective androgen receptor modulators and methods of use thereof |
| 02/16/2011 | EP2283869A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in the treatment of viral infections and cancer |
| 02/16/2011 | EP2283868A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in the treatment of viral infections and cancer |
| 02/16/2011 | EP2283865A1 Method of increasing testosterone and related steroid concentrations in women |
| 02/16/2011 | EP2283860A2 Use for interleukin-33 (il-33) and the il-33 receptor complex |
| 02/16/2011 | EP2283833A2 Amines and amides for the treatment of diseases |
| 02/16/2011 | EP2283024A1 4-aryl-2-anilino-pyrimidines as plk kinase inhibitors |
| 02/16/2011 | EP2283022A1 Furo ý3, 2-b¨pyrr0l-3-0nes as cathepsin s inhibitors |
| 02/16/2011 | EP2282759A2 Use of nucleic acids with reduced pressure therapy for treating wounds |
| 02/16/2011 | EP2282756A1 Methods of diagnosing, preventing and treating bone mass diseases |
| 02/16/2011 | EP2282743A1 Sulfated unsaturated disaccharidic chondroitin sulfate in connective tissue protection and repair |
| 02/16/2011 | EP2282736A2 Tetrazole compounds for reducing uric acid |
| 02/16/2011 | EP1424080B1 Gnrh agonist combination drugs |
| 02/16/2011 | CN1931251B Analgesic medicine composition and its preparation process and application |
| 02/16/2011 | CN1814217B Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof |
| 02/16/2011 | CN101977931A Polypeptide and pharmaceutical composition containing the polypeptide |
| 02/16/2011 | CN101977897A Methods of preparing polymorphic form a of bazedoxifene acetate |
| 02/16/2011 | CN101977624A Preparation of a pharmaceutical composition for increasing bone mineral density |
| 02/16/2011 | CN101977620A Cyclopenta[g]quinazoline derivatives for the treatment of rheumatoid arthritis or acute myeloid leukaemia |
| 02/16/2011 | CN101977609A Pharmaceutical composition for preventing and treating bone resorption of different etiology |
| 02/16/2011 | CN101977599A Composition of aqueous buffer solution for the treatment of cellular environment and ion channels and methods for using same |
| 02/16/2011 | CN101974487A Method for preparing neural stem cells with highest migration efficiency and application thereof |
| 02/16/2011 | CN101974485A Method for preparing mesenchymal stem cells with optimum transfer ability and application thereof |
| 02/16/2011 | CN101974395A Powerful antifatigue super oxide dismutase (SOD) health wine and preparation method thereof |
| 02/16/2011 | CN101974073A Anti-inflammatory hexapeptide |
| 02/16/2011 | CN101974068A Tanshinon IIA crylic acid or sodium salt thereof, preparation method and application thereof |
| 02/16/2011 | CN101973998A Pyrrolopyrimidine A2b selective antagonist compounds, their synthesis and use |
| 02/16/2011 | CN101973957A 5-benzylidene-2,4-thiazolidinedione derivatives and preparation method and application thereof |
| 02/16/2011 | CN101973938A C-ring hydrogenated sinomenine derivative and preparation method and application thereof |
| 02/16/2011 | CN101973925A 2-indolone compound with anti-inflammatory activity, preparation method and medicinal application thereof |
| 02/16/2011 | CN101973922A Atorvastatin semi-strontium salt polymorphs as well as preparation and application thereof as HMG-CoA enzyme inhibitor |
| 02/16/2011 | CN101972464A Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof |
| 02/16/2011 | CN101972453A Chinese medicinal liquor for treating rheumatic and rheumatoid arthritis and preparation method thereof |
| 02/16/2011 | CN101972386A Traditional Chinese medicine for treating diabetic gout |
| 02/16/2011 | CN101972380A Traditional Chinese medicine for treating osteoarthritis |
| 02/16/2011 | CN101972379A Traditional Chinese medicinal composition for treating ostalgia |
| 02/16/2011 | CN101972378A Traditional Chinese medicine for treating gout |
| 02/16/2011 | CN101972377A Traditional Chinese medicinal composition for treating aseptic necrosis of femoral head and preparation method thereof |
| 02/16/2011 | CN101972376A Chinese medicinal ointment for treating intervertebral disc hyperosteogeny and preparation method thereof |
| 02/16/2011 | CN101972333A Medicament for eliminating turbid urines and activating blood stasis |
| 02/16/2011 | CN101972323A Quality analysis method for loins-strengthening and kidney-invigorating oral liquid |
| 02/16/2011 | CN101972293A Externally-applied paste for treating rheumatoid bone join pain and operating method thereof |
| 02/16/2011 | CN101972287A Preparation method of Chinese astilbe extract and purpose thereof |
| 02/16/2011 | CN101972275A Gene treatment using TGF-beta secretion cell |
| 02/16/2011 | CN101972258A Immunologic suppression effect of hydroxycamptothecine and therapeutic effect of hydroxycamptothecine on rheumatoid arthritis |
| 02/16/2011 | CN101797385B Oral calcium pharmaceutical composition |
| 02/16/2011 | CN101590159B External medicament for treating ankylosing spondylitis and proliferative arthritis and processing method thereof |
| 02/16/2011 | CN101502615B Plaster for traumatic injury and bone fracture |
| 02/16/2011 | CN101371878B External-use Chinese medicinal composition for treating painful swelling disease |
| 02/16/2011 | CN101185681B Medicinal composition for treating rheumatoid arthritis and preparation method and application |
| 02/16/2011 | CN101184729B Inhibitors of cytosolic phospholipase a2 |
| 02/16/2011 | CN101069716B Chinese medicine composition for treating osteoporous and preparing method |
| 02/15/2011 | US7888458 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
| 02/15/2011 | US7888327 Methods of using immunostimulatory nucleic acid molecules to treat allergic conditions |
| 02/15/2011 | US7888056 Method of forming a peptide-receptor complex with zsig33 |
| 02/15/2011 | US7887843 Cartilage, bone,or mesenchymal stem cells are obtained from a human or animal organism are subjected to stationary culturing in a cell culture vessel with hydrophobic surface and a tapering bottom, until cell aggregate is formed |
| 02/15/2011 | US7887841 Multilayer, drug core, delay release gum compression coatings |
| 02/15/2011 | US7887799 Antibodies to fibroblast growth factor-like polypeptides |
| 02/15/2011 | US7887795 processing adipose tissue to deliver a concentrated amount of stem cells obtained from the adipose tissue to a patient; making an enhanced, autologous fat graft comprising supplementing a first portion of extracted adipose tissue with an additive and a disaggregated population of adipose-derived cells |
| 02/15/2011 | CA2624949C Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf.alpha. levels |
| 02/15/2011 | CA2558272C Pyridone derivative |
| 02/15/2011 | CA2480872C Amino acids with affinity for the .alpha.-2-.delta.-protein |
| 02/15/2011 | CA2480562C 5-substituted 1,1-dioxo-1,2,5-thiazolidine-3-one derivatives as ptpase 1b inhibitors |
| 02/15/2011 | CA2480560C .kappa.-opioid receptor agonist comprising 2-phenylbenzothiazoline derivative |
| 02/15/2011 | CA2478156C Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/15/2011 | CA2470067C Imidazoquinoline derivatives |
| 02/15/2011 | CA2449234C Quinazoline derivatives which promote the release of parathyroid hormone |
| 02/15/2011 | CA2446864C Inhibitors of src and other protein kinases |
| 02/15/2011 | CA2407046C Immunoregulator |
| 02/15/2011 | CA2377085C Substituted benzimidazoles |
| 02/15/2011 | CA2294223C Anti-cd40l immunotoxins for the treatment of diseases |
| 02/15/2011 | CA2247420C Combination therapy for osteoporosis |
| 02/10/2011 | WO2011016561A1 Dna capable of inducing osteoblast-specific expression, and nucleotide sequence for same |
| 02/10/2011 | WO2011016501A1 Prophylactic or therapeutic agent for cancer |
| 02/10/2011 | WO2011016459A1 Thienooxazepine derivative |
| 02/10/2011 | WO2010068810A3 Certain substituted amides, method of making, and method of use thereof |
| 02/10/2011 | US20110034926 Bioresorbable material |
| 02/10/2011 | US20110034568 Compositions comprising lecithin oils and NSAIDS for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
| 02/10/2011 | US20110034547 Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof |
| 02/10/2011 | US20110034543 DNA Vaccination For Treatment of Multiple Sclerosis and Insulin-Dependent Diabetes Mellitus |
| 02/10/2011 | US20110034526 Benzimidazole Compounds |
| 02/10/2011 | US20110034524 Hemi-fumarate salt of a 1,3,4-thiadiazolyl derivative as modulator of the sphingosine 1-phosphate receptor |
| 02/10/2011 | US20110034512 Indazole Compounds As CCR1 Receptor Antagonists |